Yali Xu
No.20, Chazhong Road
Fuzhou, 350005, China
Fuzhou, 350005, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
In vitro characterization of a novel anti-GD2/ROR1 bispecific antibody exhibiting tumor cell killing efficacy in neuroblastoma cross-cancer activity in ROR1-positive triple-negative breast cancer.
Journal: Translational cancer research
Published: March 27, 2026
LncRNA GAS6-AS1 enhances the progression of pediatric neuroblastoma by modulating miR-3200-3p.
Journal: World journal of surgical oncology
Published: January 13, 2026
Pre-clinical anti-tumor activity and preliminary safety of METTL3 inhibitors STM2457 and UZH1a in neuroblastoma.
Journal: Translational cancer research
Published: October 31, 2025
Tyramine-enzyme conjugate repeats for an interdigitated capacitance immunosensing array in the detection of neuroblastoma biomarker neuron-specific enolase.
Journal: The Analyst
Published: January 30, 2025
LINC00460 promotes neuroblastoma tumorigenesis and cisplatin resistance by targeting miR-149-5p/DLL1 axis and activating Notch pathway in vitro and in vivo.
Journal: Drug delivery and translational research
Published: December 18, 2023
Transcription Factor FOXO3a Overexpression Inhibits the Progression of Neuroblastoma by Regulating the miR-21/SPRY2/ERK Axis.
Journal: World neurosurgery
Published: January 19, 2022
Anticancer activity of sulforaphane against human hepatoblastoma cells involves apoptosis, autophagy and inhibition of β-catenin signaling pathway.
Journal: Archives of medical science : AMS
Published: February 19, 2020
MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
Journal: Biochimie
Published: January 29, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026